Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Fostair

- PMLiVE

NICE promises UK to lead Europe for cancer drug approvals

But industry says running the new CDF will present NICE with a ‘hugely challenging’ task

ABPI London offices

UK pharma’s contribution to NHS hits £1bn mark

ABPI says local access to new treatments still not universal despite drug rebates

ABPI appoints Mike Thompson as chief executive

He replaces acting chief executive officer Alison Clough

- PMLiVE

GSK’s severe asthma therapy Nucala gets EU nod

Becomes the first IL-5 inhibitor to be approved in the EU

- PMLiVE

Meda collaborates on asthma comic book

Launches new Explain Asthma volume at ACAAI annual meeting

- PMLiVE

GSK bags FDA approval for severe asthma drug Nucala

Drug to be launched as soon as possible

- PMLiVE

UK HCPs back transparency over their pharma payments

Survey comes as pharma companies prepare for payment disclosure database

ABPI’s Stephen Whitehead steps down

Leaves the UK pharma trade body after four years as its CEO

- PMLiVE

CHMP backs GSK’s asthma antibody and Novartis’ heart failure drug

Positive opinions for GSK's IL-5 antibody and Novartis' potential $5bn-a-year brand

ABPI London offices

Government crackdown on doctor-pharma payments

Physicians could face jail over accepting some industry gifts under new plans

ABPI Scotland appoints Sandra Auld as director

Takes over from Andrew-Powrie Smith who left to join EPFIA this year

- PMLiVE

NHS England proposes handing CDF remit to NICE

Comes after a difficult two years for the silo budget

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links